Eltrogis 50 Tablet 7's

Eltrogis 50 Tablet 7's is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltrogis 50 Tablet 7's is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.

Eltrogis 50 Tablet 7's contains 'Eltrombopag', which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone, stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Eltrogis 50 Tablet 7's works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltrogis 50 Tablet 7's helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

In some cases, Eltrogis 50 Tablet 7's can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to Eltrogis 50 Tablet 7's or any other medicines before starting Eltrogis 50 Tablet 7's. Consult the doctor if you are pregnant or planning to conceive. Eltrogis 50 Tablet 7's is not indicated for use in breastfeeding since it passes into the breast milk.

Eltrogis 50 Tablet 7's is used in the treatment of low platelet count (thrombocytopenia) in various blood-related disorders. The detailed uses of Eltrogis 50 Tablet 7's are as follows:

• Treats Chronic Immune Thrombocytopenia (ITP): Eltrogis 50 Tablet 7's is used to treat chronic ITP in patients who have not responded adequately to treatments such as immunoglobulins, corticosteroids, and splenectomy (surgical removal of spleen).
• Manages Thrombocytopenia in Hepatitis C Virus (HCV) infection: Eltrogis 50 Tablet 7's helps increase platelet counts in chronic HCV patients, making it safer for them to start and continue treatment with interferon.
• Treats Severe Aplastic Anaemia (SAA): Eltrogis 50 Tablet 7's is used for patients with SAA who have not responded to immunosuppressive treatment, helping to stimulate bone marrow to produce more blood cells.
• Prevents Bleeding Episodes: By increasing platelet count, Eltrogis 50 Tablet 7's reduces the risk of bleeding associated with low platelet levels in various blood disorders.

• Eltrogis 50 Tablet 7's can be taken on an empty stomach, at least 1 hour before or 2 hours after eating.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Swallow Eltrogis 50 Tablet 7's as a whole with a glass of water.
• Do not crush, break, or chew it.

• Eltrogis 50 Tablet 7's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults.
• Eltrogis 50 Tablet 7's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets.
• The increase in these bone marrow cells stimulates the production of platelets. Thus Eltrogis 50 Tablet 7's prevents bleeding episodes by increasing the number of platelets in the blood.

• If you are known to be allergic to Eltrogis 50 Tablet 7's or other medicines, please inform your doctor in advance.
• Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Eltrogis 50 Tablet 7's.
• Take Eltrogis 50 Tablet 7's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltrogis 50 Tablet 7's.
• Eltrogis 50 Tablet 7's is not recommended during pregnancy since it may have harmful effects on the foetus.
• Consult your doctor before using Eltrogis 50 Tablet 7's if you are a breastfeeding mother.
• Do not drive or operate machinery since Eltrogis 50 Tablet 7's may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive.
• Avoid or limit alcohol consumption with Eltrogis 50 Tablet 7's as it may affect the efficacy of Eltrogis 50 Tablet 7's.
• Eltrogis 50 Tablet 7's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.